CDKN2A and head and neck squamous cell carcinoma: Notably, CDKN2A promoter methylation is another mechanism of CDKN2A inactivation, which is known to be common in HNSCC as a whole (20% of cases in TCGA data [28]) but could not be evaluated in our cohort.